{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,4]],"date-time":"2026-05-04T01:32:53Z","timestamp":1777858373736,"version":"3.51.4"},"reference-count":28,"publisher":"SAGE Publications","issue":"2_suppl","license":[{"start":{"date-parts":[[1995,3,1]],"date-time":"1995-03-01T00:00:00Z","timestamp":794016000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["J Psychopharmacol"],"published-print":{"date-parts":[[1995,3]]},"abstract":"<jats:p>Anxiety symptoms are commonly associated with depression, and contribute to a poorer patient prognosis. An increase in serotonergic function is implicated in the pathogenesis of anxiety and there is good evidence that the selective serotonin re-uptake inhibitors (SSRIs) may be useful in clinical management. Sertraline, a novel SSRI, has been shown to be effective in the treatment of anxiety symptoms in both pure and mixed anxiety disorders. Studies have also shown sertraline to be effective in obsessive-compulsive disorder. A recent study (Moon et al., 1994) shows sertraline to have comparative therapeutic efficacy with that of clomipramine with respect to reduction of anxiety symptoms in depression. However, it also highlights important differences in side-effect profiles, with a high incidence of cardiovascular effects and subsequent dropouts reported in the clomipramine group. Limited comparative data with other SSRIs suggest there is no evidence of any aggravation of anxiety symptoms during treatment with sertraline, as has been reported with fluoxetine. Sertraline has been shown to have a normalising effect on sleep disturbance in depression without evidence of daytime sedation. Therefore, given the high prevalence of anxiety symptoms in depression, sertraline would be a useful therapeutic option in clinical management.<\/jats:p>","DOI":"10.1177\/0269881195009002031","type":"journal-article","created":{"date-parts":[[2017,7,17]],"date-time":"2017-07-17T19:28:43Z","timestamp":1500319723000},"page":"185-189","source":"Crossref","is-referenced-by-count":4,"title":["The anxiety factor in depression"],"prefix":"10.1177","volume":"9","author":[{"given":"David","family":"Nutt","sequence":"first","affiliation":[{"name":"Psychopharmacology Unit, University of Bristol, Bristol, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"179","published-online":{"date-parts":[[1995,3,1]]},"reference":[{"key":"bibr1-0269881195009002031","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/00004850-199300830-00010","volume":"8","author":"Aguglia E","year":"1993","journal-title":"Int Clin Psychopharmacol"},{"key":"bibr2-0269881195009002031","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1097\/00005053-199011000-00004","volume":"178","author":"Alnaes R","year":"1990","journal-title":"J Nerv Ment Dis"},{"key":"bibr3-0269881195009002031","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/BF00380990","volume":"235","author":"Angst J","year":"1985","journal-title":"Eur Arch Psychiatr Neurol Sci"},{"key":"bibr4-0269881195009002031","unstructured":"Bennie E H (1993) Double blind study of sertraline and fluoxetine in outpatients with major depression. Presented at the 9th World Congress of Psychiatry. Rio de Janiero, Brazil, 6-12 June, 1993"},{"key":"bibr5-0269881195009002031","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/026988119300700106","volume":"7","author":"Burton S W","year":"1993","journal-title":"J Psychopharmacol"},{"key":"bibr6-0269881195009002031","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1007\/BF00215473","volume":"92","year":"1987","journal-title":"Psychopharmacology"},{"key":"bibr7-0269881195009002031","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1176\/ajp.148.11.1512","volume":"148","author":"Clayton P J","year":"1991","journal-title":"Am J Psychiatr"},{"key":"bibr8-0269881195009002031","unstructured":"Data on file (UK 90-002) Invicta Pharmaceuticals, Sandwich, Kent"},{"key":"bibr9-0269881195009002031","doi-asserted-by":"crossref","unstructured":"Fontaine R, (1991) The efficacy and safety of sertraline versus imipramine in out-patients with major depression: a six-month, double-blind, parallel multicentre study. Presented at the IVth ECNP, Monte Carlo, Monaco, 6-9 October 1991 (Poster)","DOI":"10.1016\/0924-977X(91)90658-H"},{"issue":"2","key":"bibr10-0269881195009002031","first-page":"16","volume":"54","author":"Glassman A H","year":"1993","journal-title":"J Clin Psychiatr"},{"key":"bibr11-0269881195009002031","first-page":"225","volume":"47","author":"Goldman L S","year":"1986","journal-title":"J Clin Psychiatr"},{"key":"bibr12-0269881195009002031","unstructured":"Gorman J, Wolkow R (1994) Sertraline as a treatment for panic disorder. Presented at the XIXth Collegium Internationale Neuro-Psychopharmacologicum Congress, Washington DC, USA, June 27-July 1 1994 (Poster)"},{"issue":"5","key":"bibr13-0269881195009002031","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00004850-199206005-00003","volume":"6","author":"Humble M","year":"1992","journal-title":"Int Clin Psychopharmacol"},{"key":"bibr14-0269881195009002031","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1007\/BF00216062","volume":"96","author":"Kahn R S","year":"1988","journal-title":"Psychopharmacology"},{"key":"bibr15-0269881195009002031","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1037\/0021-843X.100.3.337","volume":"100","author":"Katon W","year":"1991","journal-title":"J Abnorm Psychol"},{"issue":"2","key":"bibr16-0269881195009002031","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1097\/00004850-199112002-00005","volume":"6","author":"Lapierre Y D","year":"1991","journal-title":"Int Clin Psychopharmacol"},{"issue":"2","key":"bibr17-0269881195009002031","first-page":"10","volume":"54","author":"Liebowitz M R","year":"1993","journal-title":"J Clin Psychiatr"},{"issue":"2","key":"bibr18-0269881195009002031","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1097\/00004850-199210002-00005","volume":"7","author":"Mendels J","year":"1992","journal-title":"Int Clin Psychopharmacol"},{"key":"bibr19-0269881195009002031","unstructured":"Moon C A L, Wood K, Lane R M, (1993) Sertraline and clomipramine in mixed anxiety depression. Presented at the British Association of Psychopharmacology Meeting. Cambridge, UK, July 25-28, 1993"},{"key":"bibr20-0269881195009002031","doi-asserted-by":"crossref","unstructured":"Moon C A L, Jago W, Wood K, Doogan D P (1994) A double-blind comparison of sertraline and clomipramine in the treatment of major depressive disorder and associated anxiety in general practice. Poster presented at XIXth CINP, Washington, USA, 27 June-1 July 1994","DOI":"10.1177\/026988119400800306"},{"key":"bibr21-0269881195009002031","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1177\/070674379003500505","volume":"35","author":"Murphy J M","year":"1990","journal-title":"Can J Psychiatr"},{"key":"bibr22-0269881195009002031","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1017\/S0033291700025848","volume":"17","author":"Nutt D J","year":"1987","journal-title":"Psychol Med"},{"key":"bibr23-0269881195009002031","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1056\/NEJM198702123160702","volume":"316","author":"Ray W A","year":"1987","journal-title":"N Engl J Med"},{"issue":"12","key":"bibr24-0269881195009002031","first-page":"18","volume":"51","author":"Reimherr F W","year":"1990","journal-title":"J Clin Psychiatr"},{"key":"bibr25-0269881195009002031","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/ddr.430080124","volume":"8","author":"Reyntjens A","year":"1986","journal-title":"Drug Dev Res"},{"key":"bibr26-0269881195009002031","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00004714-199004000-00007","volume":"10","author":"Schneier F F","year":"1990","journal-title":"J Clin Psychopharmacol"},{"key":"bibr27-0269881195009002031","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1192\/bjp.149.1.7","volume":"149","author":"Stavrakaki C","year":"1986","journal-title":"Br J Psychiatr"},{"key":"bibr28-0269881195009002031","first-page":"84B","volume":"15","author":"Winokur A","year":"1992","journal-title":"In: Clin Neuropharmacol"}],"container-title":["Journal of Psychopharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0269881195009002031","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1177\/0269881195009002031","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T00:12:00Z","timestamp":1777507920000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1177\/0269881195009002031"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1995,3]]},"references-count":28,"journal-issue":{"issue":"2_suppl","published-print":{"date-parts":[[1995,3]]}},"alternative-id":["10.1177\/0269881195009002031"],"URL":"https:\/\/doi.org\/10.1177\/0269881195009002031","relation":{},"ISSN":["0269-8811","1461-7285"],"issn-type":[{"value":"0269-8811","type":"print"},{"value":"1461-7285","type":"electronic"}],"subject":[],"published":{"date-parts":[[1995,3]]}}}